期刊文献+

Functional endothelial cells derived from embryonic stem cells labeled with HIV transactivator peptide-conjugated superparamagnetic nanoparticles 被引量:2

Functional endothelial cells derived from embryonic stem cells labeled with HIV transactivator peptide-conjugated superparamagnetic nanoparticles
原文传递
导出
摘要 Background The development of regenerative therapies using derivatives of embryonic stem (ES) cells would be facilitated by a non-invasive method to monitor transplanted cells in vivo, for example, magnetic resonance imaging of cells labeled with superparamagnetic iron oxide (SPIO) nanoparticles. Although ES cells have been labeled with SPIO particles, the potential adverse effects of the label have not been fully examined. The objective of this study was to determine whether SPIO labeling affects routine ES cell viability, proliferation, or ability to differentiate into functional endothelial cells (ECs). Methods Cross-linked iron oxide (CLIO, an SPIO) was conjugated with human immunodeficiency virus transactivator of transcription (HIV-Tat) peptides, and murine ES cells were labeled with either CLIO-Tat, CLIO, or HIV-Tat. After labeling ES cells were cultured for 4 days and FIk-1^+ ES cells identified and sorted by immunocytochemistry and fluorescence activated cell sorting (FACS). FIk-1^+ cells were replated on fibronectin-coated dishes, and ECs were obtained by culturing these for 4 weeks in endothelial cell growth medium supplemented with vascular endothelial growth factor (VEGF). ES cell viability was determined using trypan blue exclusion, and the proportion of SPIO^+ cells was evaluated using Prussian blue staining and transmission electron microscopy. After differentiation, the behavior and phenotype of ECs were analyzed by reverse transcription-polymerase chain reaction, flow cytometry, immunocytochemistry, Dil-labeled acetylated low-density lipoprotein (AcLDL) uptake, and Matrigel tube formation assay. Results CLIO-Tat was a highly effective label for ES cells, with 〉96% of cells incorporating the particles, and it did not alter the viability of the labeled cells. ECs derived from CLIO-Tat^+ ES cells were very similar to murine aortic ECs in their morphology, expression of endothelial cell markers, ability to form vascular-like channels, and scavenging of AcLDL from the culture medium. Conclusions CLIO-Tat is a highly effective label for ES cells and does not adversely affect cell viability, differentiation, or behavior. CLIO-Tat could be a useful marker for the non-invasive monitoring of transplanted stem cells. Background The development of regenerative therapies using derivatives of embryonic stem (ES) cells would be facilitated by a non-invasive method to monitor transplanted cells in vivo, for example, magnetic resonance imaging of cells labeled with superparamagnetic iron oxide (SPIO) nanoparticles. Although ES cells have been labeled with SPIO particles, the potential adverse effects of the label have not been fully examined. The objective of this study was to determine whether SPIO labeling affects routine ES cell viability, proliferation, or ability to differentiate into functional endothelial cells (ECs). Methods Cross-linked iron oxide (CLIO, an SPIO) was conjugated with human immunodeficiency virus transactivator of transcription (HIV-Tat) peptides, and murine ES cells were labeled with either CLIO-Tat, CLIO, or HIV-Tat. After labeling ES cells were cultured for 4 days and FIk-1^+ ES cells identified and sorted by immunocytochemistry and fluorescence activated cell sorting (FACS). FIk-1^+ cells were replated on fibronectin-coated dishes, and ECs were obtained by culturing these for 4 weeks in endothelial cell growth medium supplemented with vascular endothelial growth factor (VEGF). ES cell viability was determined using trypan blue exclusion, and the proportion of SPIO^+ cells was evaluated using Prussian blue staining and transmission electron microscopy. After differentiation, the behavior and phenotype of ECs were analyzed by reverse transcription-polymerase chain reaction, flow cytometry, immunocytochemistry, Dil-labeled acetylated low-density lipoprotein (AcLDL) uptake, and Matrigel tube formation assay. Results CLIO-Tat was a highly effective label for ES cells, with 〉96% of cells incorporating the particles, and it did not alter the viability of the labeled cells. ECs derived from CLIO-Tat^+ ES cells were very similar to murine aortic ECs in their morphology, expression of endothelial cell markers, ability to form vascular-like channels, and scavenging of AcLDL from the culture medium. Conclusions CLIO-Tat is a highly effective label for ES cells and does not adversely affect cell viability, differentiation, or behavior. CLIO-Tat could be a useful marker for the non-invasive monitoring of transplanted stem cells.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第2期298-303,共6页 中华医学杂志(英文版)
基金 This work was supported by a grant from the National Natural Science Foundation of China (No. 30571821).
关键词 embryonic stem cells endothelial cells cell differentiation FERUMOXIDES embryonic stem cells endothelial cells cell differentiation ferumoxides
  • 相关文献

参考文献24

  • 1Rosenthal N.Prometheus's vulture and the stem-cell promise.N Engl J Med 2003;349:267-274.
  • 2Borysiewicz L.Banking on the future of stem cells.Leszek Borysiewicz,head of the UK Medical Research Council (MRC),interviewed by Monya Baker.Nature 2008;452:263.
  • 3Nishikawa S,Jakt LM,Era T.Embryonic stem-cell culture as a tool for developmental cell biology.Nat Rev Mol Cell Biol 2007;8:502-507.
  • 4Nishikawa SI,Nishikawa S,Hirashima M,Matsuyoshi N,Kodama H.Progressive lineage analysis by cell sorting and culture identifies FLKl+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages.Development 1998;125:1747-1757.
  • 5Hirashima M,Kataoka H,Nishikawa S,Matsuyoshi N.Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis.Blood 1999;93:1253-1263.
  • 6McCloskey KE,Lyons I,Rao RR,Stice SL,Nerem RM.Purified and proliferating endothelial cells derived and expanded in vitro from embryonic stem cells.Endothelium 2003;10:329-336.
  • 7Levenberg S,Golub JS,Amit M,Itskovitz-Eldor J,Langer R.Endothelial cells derived from human embryonic stem cells.Proc Natl Acad Sci U S A 2002;99:4391-4396.
  • 8Kaufman DS,Lewis RL,Hanson ET,Auerbach R,Plendl J,Thomson JA.Functional endothelial cells derived from rhesus monkey embryonic stem cells.Blood.2004;103:1325-1332.
  • 9Cho SW,Moon SH,Lee SH,Kang SW,Kim J,Lim JM,et al.Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia.Circulation 2007;116:2409-2419.
  • 10Li Z,Wu JC,Sheikh AY,Kraft D,Cao F,Xie X,et al.Differentiation,survival,and function of embryonic stem cell derived endothelial cells for ischemic heart disease.Circulation 2007;116:146-154.

同被引文献12

  • 1朱文珍,李祥,漆剑频,夏黎明,王承缘,魏黎,雷皓.神经干细胞超顺磁性氧化铁标记及体内外MRI示踪[J].中华放射学杂志,2006,40(2):160-164. 被引量:11
  • 2Li Z, Wu JC, Sheikh AY, et al. Differentiation, survival, and function of embryonic stem ceil ierived endothe|ial cells for ischemic heart disease [J]. Circulation, 2007, 116 (11 SuppD :146-154.
  • 3Li Z, Han Z, Wu JC. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases [J]. J Cell Biochem,2009, 106(2) :194-199.
  • 4Nishikawa SI, Nishikawa S, Hirashima M, et al. Progressive lineage analysis by cell sorting and culture identifies FLK1 + VE cadherin + cells at a diw~rging point of endothelial and hemopoietic lineages [J]. Development, 1998, 125(9) :1747-1757.
  • 5Wang R, Clark R, Bautch VI.. Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development [J]. Development, 1992, 114(2) :303-316.
  • 6Li Z, Suzuki Y, Huang M, et aI. Comparison of reporter gene and iron particle labeling for tracking fate of human em- bryonic stem cells and differentiated endothelial cells in living subiects [J]. Stem Cells,2008, 26(4) :864-873.
  • 7Levenberg S, Golub JS, Amit M, et al. Endothelial cells de rived from human embryonic stem cells [J]. Proc Natl Acad Sci U S A, 2002, 99(7):4391-4396.
  • 8Gimond C, Marchetti S, Pages G. Differentiation of mouse embryonic stem cells into endothelial cells: genetic selection and potential use in vivo [M]. Methods Mol Biol, 2006, 330 (2) :303-329.
  • 9McCloskey KE, Lyons l, Rao RR, et al. Purified and prolif erating endothelial cells derived and expanded in vitro from embryonic stem cells[J ]. Endothelium, 2003, 10 (6): 329- 336.
  • 10Yamashita J, ltoh H, Hirashiraa M, et al. Flkl- positive cells derived from embryonic stem cells serve as vascular progeni- tors [J]. Nature, 2000. 408(6808) :92-96.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部